Adipose Tissue Dysfunction: Clinical Relevance and Diagnostic Possibilities

被引:21
|
作者
Schrover, I. M. [1 ]
Spiering, W. [1 ]
Leiner, T. [2 ]
Visseren, F. L. J. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
关键词
adipose tissue; dysfunction; diagnosis; metabolic syndrome; BODY-MASS INDEX; CORONARY-HEART-DISEASE; RETINOL-BINDING-PROTEIN; METABOLIC RISK-FACTORS; MAGNETIC-RESONANCE-SPECTROSCOPY; MOLECULAR-WEIGHT ADIPONECTIN; VISCERAL FAT ACCUMULATION; ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; WAIST CIRCUMFERENCE;
D O I
10.1055/s-0042-103243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adipose tissue dysfunction is defined as an imbalance between pro- and anti-inflammatory adipokines, causing insulin resistance, systemic low-grade inflammation, hypercoagulability, and elevated blood pressure. These can lead to cardiovascular disease and diabetes mellitus type 2. Although quantity of adipose tissue is an important determinant of adipose tissue dysfunction, it can be diagnosed in both obese and lean individuals. This implies that not only quantity of adipose tissue should be used as a measure for adipose tissue dysfunction. Instead, focus should be on measuring quality of adipose tissue, which can be done with diagnostic modalities ranging from anthropometric measurements to tissue biopsies and advanced imaging techniques. In daily clinical practice, high quantity of visceral adipose tissue (reflected in high waist circumference or adipose tissue imaging), insulin resistance, or presence of the metabolic syndrome are easy and low-cost diagnostic modalities to evaluate presence or absence of adipose tissue dysfunction.
引用
收藏
页码:213 / 225
页数:13
相关论文
共 50 条
  • [1] Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management
    van de Woestijne, A. P.
    Monajemi, H.
    Kalkhoven, E.
    Visseren, F. L. J.
    OBESITY REVIEWS, 2011, 12 (10) : 829 - 840
  • [2] Plasticizers and Cardiovascular Health: Role of Adipose Tissue Dysfunction
    Callaghan, Mikyla A.
    Alatorre-Hinojosa, Samuel
    Connors, Liam T.
    Singh, Radha D.
    Thompson, Jennifer A.
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [3] Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor
    Parasiliti-Caprino, Mirko
    Bollati, Martina
    Merlo, Fabio Dario
    Ghigo, Ezio
    Maccario, Mauro
    Bo, Simona
    NUTRIENTS, 2022, 14 (22)
  • [4] Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
    Villasante Fricke, Alexandra C.
    Iacobellis, Gianluca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
  • [5] Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
    Bril, Fernando
    Ezeh, Uche
    Amiri, Mina
    Hatoum, Sana
    Pace, Lauren
    Chen, Yen-Hao
    Bertrand, Fred
    Gower, Barbara
    Azziz, Ricardo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (01) : 10 - 24
  • [6] Understanding Adipose Tissue Dysfunction
    Blueher, Matthias
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2024, 33 (04) : 275 - 288
  • [7] Adipose Tissue Dysfunction in Obesity
    Bluehre, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (06) : 241 - 250
  • [8] Adipose tissue inflammation and metabolic dysfunction: a clinical perspective
    Tam, Charmaine S.
    Redman, Leanne M.
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2013, 15 (01) : 19 - 24
  • [9] Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression
    Gucalp, Ayca
    Iyengar, Neil M.
    Hudis, Clifford A.
    Dannenberg, Andrew J.
    SEMINARS IN ONCOLOGY, 2016, 43 (01) : 154 - 160
  • [10] Mitochondrial dysfunction in white adipose tissue
    Kusminski, Christine M.
    Scherer, Philipp E.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2012, 23 (09) : 435 - 443